Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.

Nanoparticles with multifunctionality are being designed and formulated to overcome various limitations of drugs as well as conventional drug delivery systems. Engineered nanoparticles to specifically target cancer cells have the ability to reduce collateral damage on normal tissue due to pan-toxic effects of drugs. Pragmatic approaches are being in consideration to make advancement in cancer therapy as the new developed methods exhibited an improved targeted anticancer therapeutic delivery with better treatment outcomes. An effective cancer therapy requires both the passive and active targeting to successfully achieve targeted delivery. The nanoparticles can be conjugated with specific ligands, antibodies and carbohydrates for active targeting of cancer cells with great affinity and precision. This review presents some recent strategies such as immunotherapy, role of cell sex and protein corona in for targeted cancer therapy and also discusses some examples of engineered nanoparticles exploited for active cancer targeting and their limitations and associated toxicity.

[1]  D. Han,et al.  New opportunities for nanoparticles in cancer immunotherapy , 2018, Biomaterials Research.

[2]  A. Minn,et al.  Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies. , 2018, Immunity.

[3]  Shou-Cheng Wu,et al.  Development of a mucin4-targeting SPIO contrast agent for effective detection of pancreatic tumor cells in vitro and in vivo. , 2013, Journal of medicinal chemistry.

[4]  V. Apostolopoulos,et al.  Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] , 2006, Breast Cancer Research.

[5]  H. Shmeeda,et al.  Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Miqin Zhang,et al.  Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. , 2010, Nanomedicine.

[7]  Qin Liu,et al.  AMP-guided tumour-specific nanoparticle delivery via adenosine A1 receptor. , 2016, Biomaterials.

[8]  G. Yaari,et al.  Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy. , 2017, ACS nano.

[9]  Y. Assaraf,et al.  The folate receptor as a rational therapeutic target for personalized cancer treatment. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[10]  Redouane Borsali,et al.  Rodlike Cellulose Microcrystals: Structure, Properties, and Applications , 2004 .

[11]  V. Herrera,et al.  Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells. , 2018, Nanomedicine.

[12]  K. Maruyama,et al.  Intracellular targeting therapy of cisplatin‐encapsulated transferrin‐polyethylene glycol liposome on peritoneal dissemination of gastric cancer , 2002, International journal of cancer.

[13]  A. Goodchild,et al.  Targeting somatostatin receptors using in situ-bioconjugated fluorescent nanoparticles. , 2012, Nanomedicine.

[14]  S. Thayumanavan,et al.  Dendrimeric micelles for controlled drug release and targeted delivery. , 2005, Molecular pharmaceutics.

[15]  A. Farooqi,et al.  Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy. , 2016, Current pharmaceutical design.

[16]  P. Fishman,et al.  A3 adenosine receptor as a target for cancer therapy. , 2002, Anti-cancer drugs.

[17]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[18]  I. Lynch,et al.  A high throughput imaging database of toxicological effects of nanomaterials tested on HepaRG cells , 2019, Scientific Data.

[19]  Irwin Hollander,et al.  Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. , 2002, Bioconjugate chemistry.

[20]  Morteza Mahmoudi,et al.  Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies. , 2018, Trends in biotechnology.

[21]  P. Trail,et al.  Synthesis and antitumor activity of the immunoconjugate BR96-Dox , 1996 .

[22]  Rehan Khan,et al.  Nanocarrier Composed of Magnetite Core Coated with Three Polymeric Shells Mediates LCS-1 Delivery for Synthetic Lethal Therapy of BLM-Defective Colorectal Cancer Cells. , 2018, Biomacromolecules.

[23]  M. Vandana,et al.  Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[24]  C. Mai,et al.  Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy , 2018, Front. Pharmacol..

[25]  K. Aboody,et al.  Concise Review: Neural Stem Cell‐Mediated Targeted Cancer Therapies , 2018, Stem cells translational medicine.

[26]  K. Sachs,et al.  Variation of Immune Cell Responses in Humans Reveals Sex-Specific Coordinated Signaling Across Cell Types , 2019, bioRxiv.

[27]  H. Davies,et al.  Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro , 2013, PloS one.

[28]  K. B. Sutradhar,et al.  Nanotechnology in Cancer Drug Delivery and Selective Targeting , 2014 .

[29]  Miqin Zhang,et al.  Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery. , 2015, ACS macro letters.

[30]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[31]  Mingwu Shen,et al.  Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. , 2015, Analytical chemistry.

[32]  M. D. Blanco,et al.  Targeted Nanoparticles for Cancer Therapy , 2012 .

[33]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[34]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[35]  Dan Peer,et al.  Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.

[36]  M. Wicha,et al.  Modeling of Interactions between Cancer Stem Cells and their Microenvironment: Predicting Clinical Response. , 2018, Methods in molecular biology.

[37]  Huiling Mu,et al.  The potential of protein-nanomaterial interaction for advanced drug delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[38]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[39]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[40]  W. Zhou,et al.  Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes , 2010, Nanotechnology.

[41]  G. Bendas,et al.  Vascular cell adhesion molecule‐1 (VCAM‐1)—An increasing insight into its role in tumorigenicity and metastasis , 2015, International journal of cancer.

[42]  A. Ullrich,et al.  Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.

[43]  H. Goike,et al.  Clinical utility of cytokeratins as tumor markers. , 2004, Clinical biochemistry.

[44]  Sílvia A. Ferreira,et al.  Self-assembled mannan nanogel: cytocompatibility and cell localization. , 2012, Journal of biomedical nanotechnology.

[45]  Xiaoxiao Jin,et al.  Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells , 2017, Journal of experimental & clinical cancer research : CR.

[46]  M. Nireekshan Kumar,et al.  Gelatin-Coated Polycaprolactone Nanoparticle-Mediated Naringenin Delivery Rescue Human Mesenchymal Stem Cells from Oxygen Glucose Deprivation-Induced Inflammatory Stress. , 2018, ACS biomaterials science & engineering.

[47]  Conroy Sun,et al.  Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.

[48]  Forrest M Kievit,et al.  A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. , 2009, Biomaterials.

[49]  Ching-Seng Ang,et al.  Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas. , 2015, ACS nano.

[50]  Hiroyuki Honda,et al.  Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. , 2004, Cancer Letters.

[51]  Huile Gao,et al.  Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona. , 2018, ACS applied materials & interfaces.

[52]  Yueqing Gu,et al.  Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification , 2017, Theranostics.

[53]  Yongjiang Zheng,et al.  Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells , 2017, Front. Pharmacol..

[54]  Miqin Zhang,et al.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. , 2010, Molecular pharmaceutics.

[55]  K. Leong,et al.  Graphene oxide cellular patches for mesenchymal stem cell-based cancer therapy , 2017 .

[56]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[57]  T. Visser,et al.  Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives , 2001, European Journal of Nuclear Medicine.

[58]  F. Du,et al.  Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. , 2014, Biomaterials.

[59]  Pauliina Kronqvist,et al.  Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  D. Raucher,et al.  Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives , 2018, Front. Oncol..

[61]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[62]  E. Frenkel,et al.  Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.

[63]  Ueli Aebi,et al.  Intermediate filaments: from cell architecture to nanomechanics , 2007, Nature Reviews Molecular Cell Biology.

[64]  V. Canzonieri,et al.  Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin. , 2019, ACS medicinal chemistry letters.

[65]  A. Yaghmur,et al.  Nanomedicines for cancer therapy: current status, challenges and future prospects. , 2019, Therapeutic delivery.

[66]  A. Mohr,et al.  The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts. , 2018, Cancer letters.

[67]  T. Graeber,et al.  Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer , 2018, Proceedings of the National Academy of Sciences.

[68]  R. Coleman,et al.  Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer. , 2013, Gynecologic oncology.

[69]  P. Rai,et al.  Cancer nanomedicine: a review of recent success in drug delivery , 2017, Clinical and Translational Medicine.

[70]  Tianliang Li,et al.  Cytokine induced killer cells-assisted delivery of chlorin e6 mediated self-assembled gold nanoclusters to tumors for imaging and immuno-photodynamic therapy. , 2018, Biomaterials.

[71]  Donghoon Lee,et al.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. , 2008, Nanomedicine.

[72]  H. Wong,et al.  Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[73]  R. Stauber,et al.  The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM). , 2016, Toxicology and applied pharmacology.

[74]  A. Rotte,et al.  Immunotherapy of melanoma: Present options and future promises , 2015, Cancer and Metastasis Reviews.

[75]  L. Kong,et al.  Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon , 2015, Journal of microencapsulation.

[76]  C. T. Hagan,et al.  Nanotechnology Approaches to Improving Cancer Immunotherapy. , 2018, Advances in cancer research.

[77]  C. Li,et al.  Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer. , 2015, Biomaterials.

[78]  Yong Chen,et al.  Targeted polysaccharide nanoparticle for adamplatin prodrug delivery. , 2013, Journal of medicinal chemistry.

[79]  G. Storm,et al.  Towards clinical translation of ligand‐functionalized liposomes in targeted cancer therapy: Challenges and opportunities , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Sílvia A. Ferreira,et al.  Supramolecular assembled nanogel made of mannan. , 2011, Journal of colloid and interface science.

[81]  Francesco Salvatore,et al.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.

[82]  K. Landfester,et al.  Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.

[83]  Horst Kessler,et al.  Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD , 2005, PLoS medicine.

[84]  Jing Liu,et al.  Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol–dihydroartemisinin conjugate , 2016, Scientific Reports.

[85]  Hodson Laura,et al.  An evaluation of engineered nanomaterial safety data sheets for safety and health information post implementation of the revised hazard communication standard. , 2019, Journal of chemical health & safety.

[86]  P. Trail,et al.  Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. , 1993, Science.

[87]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[88]  M. Dhaenens,et al.  Plasma Functionalization of Polycaprolactone Nanofibers Changes Protein Interactions with Cells, Resulting in Increased Cell Viability. , 2018, ACS applied materials & interfaces.

[89]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[90]  R. Mishra,et al.  Zinc Gluconate-Loaded Chitosan Nanoparticles Reduce Severity of Collagen-Induced Arthritis in Wistar Rats. , 2019, ACS biomaterials science & engineering.

[91]  Hong Sun,et al.  Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. , 2017, Oncology reports.

[92]  Omid C. Farokhzad,et al.  α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. , 2012, ACS nano.

[93]  Kan Wang,et al.  Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy. , 2016, ACS nano.

[94]  Aristidis Tsatsakis,et al.  Protein bio-corona: critical issue in immune nanotoxicology , 2016, Archives of Toxicology.

[95]  T. Ochiya,et al.  Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[96]  Alain Dufresne,et al.  Nanocellulose in biomedicine: Current status and future prospect , 2014 .

[97]  D. Mooney,et al.  Biomaterial-assisted targeted modulation of immune cells in cancer treatment , 2018, Nature Materials.

[98]  C. Figdor,et al.  Synthetic immune niches for cancer immunotherapy , 2017, Nature Reviews Immunology.

[99]  Ralph Weissleder,et al.  Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.

[100]  Rehan Khan,et al.  Synthetic Lethality: From Research to Precision Cancer Nanomedicine. , 2018, Current cancer drug targets.

[101]  RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells , 2015, Drug Delivery and Translational Research.

[102]  Tian Zhang,et al.  Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[103]  Y. Bae,et al.  Perspectives on the past, present, and future of cancer nanomedicine. , 2018, Advanced drug delivery reviews.

[104]  J. Cochran,et al.  Targeting ligand-receptor interactions for development of cancer therapeutics. , 2017, Current opinion in chemical biology.

[105]  J. Byrd,et al.  CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia. , 2015, Molecular pharmaceutics.

[106]  P. Low,et al.  Folate-targeted therapies for cancer. , 2010, Journal of medicinal chemistry.

[107]  Farren J. Isaacs,et al.  Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug. , 2018, Nano letters (Print).

[108]  M. Mahmoudi.  Antibody orientation determines corona mistargeting capability , 2018, Nature Nanotechnology.

[109]  Balu Ranganathan,et al.  Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. , 2008, Biomaterials.

[110]  P. Rai,et al.  Nanoparticle Design Strategies for Effective Cancer Immunotherapy. , 2017, Journal of Biomedicine.

[111]  Ke Xu,et al.  Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface. , 2018, ACS nano.

[112]  D. Cui,et al.  Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy , 2016, Nanoscale Research Letters.

[113]  V. Torchilin,et al.  Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer , 2018, Drug delivery.

[114]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[115]  C. Gasch,et al.  Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention , 2017, Molecular Cancer.

[116]  Wahid Khan,et al.  Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. , 2015, International journal of pharmaceutics.

[117]  H. Sontheimer,et al.  Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.

[118]  T. Maekawa,et al.  Multifunctional carboxymethyl cellulose-based magnetic nanovector as a theragnostic system for folate receptor targeted chemotherapy, imaging, and hyperthermia against cancer. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[119]  G. Coceano,et al.  Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells , 2016, Scientific Reports.

[120]  T. Minko.  Drug targeting to the colon with lectins and neoglycoconjugates. , 2004, Advanced drug delivery reviews.

[121]  M. Mahmoudi,et al.  Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors. , 2016, ACS applied materials & interfaces.

[122]  J. Fisher,et al.  Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[123]  T. Papoian,et al.  Safety of antisense oligonucleotide and siRNA-based therapeutics. , 2017, Drug discovery today.

[124]  Prince Sharma,et al.  Mannanases: microbial sources, production, properties and potential biotechnological applications , 2012, Applied Microbiology and Biotechnology.

[125]  C. Eberhart,et al.  Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival. , 2018, Nano letters.

[126]  Jian Zhao,et al.  Electrical-Charge-Mediated Cancer Cell Targeting via Protein Corona-Decorated Superparamagnetic Nanoparticles in a Simulated Physiological Environment. , 2018, ACS applied materials & interfaces.

[127]  G. Koning,et al.  EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery. , 2016, Colloids and surfaces. B, Biointerfaces.

[128]  Peixuan Guo,et al.  Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy. , 2018, Cancer letters.

[129]  Zuanguang Chen,et al.  Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy , 2017, Front. Pharmacol..

[130]  Susan Hua,et al.  Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization , 2018, Front. Pharmacol..

[131]  Md. Ali Mujtaba,et al.  Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics , 2018, Artificial cells, nanomedicine, and biotechnology.

[132]  M. Jaggi,et al.  Design of curcumin loaded cellulose nanoparticles for prostate cancer. , 2012, Current drug metabolism.

[133]  Liang Yan,et al.  A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines , 2019, Advanced materials.

[134]  N. Erdoğar,et al.  Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy , 2018 .

[135]  C. K. Das,et al.  Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. , 2017, Cancer letters.

[136]  Jarno Salonen,et al.  Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy , 2016, Advanced materials.

[137]  N. Neamati,et al.  Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. , 2016, Journal of medicinal chemistry.

[138]  N. Yusuf,et al.  Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting. , 2018, Biomacromolecules.

[139]  Manuel Arruebo,et al.  Antibody-conjugated nanoparticles for biomedical applications , 2009 .

[140]  Jun Chen,et al.  Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality. , 2018, Biomaterials.

[141]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[142]  P. Storz,et al.  Targeting reactive oxygen species in development and progression of pancreatic cancer , 2017, Expert review of anticancer therapy.

[143]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[144]  S. Gurunathan,et al.  Biocompatible Gold Nanoparticles Ameliorate Retinoic Acid-Induced Cell Death and Induce Differentiation in F9 Teratocarcinoma Stem Cells , 2018, Nanomaterials.

[145]  Jinho Park,et al.  Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.

[146]  G. Bendas,et al.  VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.